Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET
May 19, 2024 08:00 ET
|
Dyne Therapeutics, Inc.
WALTHAM, Mass., May 19, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for...
LGI Homes Commemorates Annual Service Impact Day and Celebrates Employee Volunteerism
May 17, 2024 18:43 ET
|
LGI Homes, Inc.
Every LGI Homes employee turns from their focus on sales and closings and dedicates an entire day to supporting local charities through volunteerism
Pineapple Energy Announces Chief Executive Officer Transition
May 17, 2024 18:41 ET
|
Pineapple Energy
Pineapple Energy Announces Chief Executive Officer Transition
Verizon supports Texas and Louisiana communities affected by recent storms
May 17, 2024 18:30 ET
|
Verizon Sourcing LLC
For media: we have b-roll, pictures and additional information on our emergency response equipment available at our Emergency Resource Center. What you need to know: Verizon is waiving...
Millicom (Tigo) share repurchase activity
May 17, 2024 17:30 ET
|
Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, May 17, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 36,701 of its Swedish Depository...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 17, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
May 17, 2024 17:00 ET
|
Achilles Therapeutics PLC
LONDON, May 17, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal...
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
May 17, 2024 17:00 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., May 17, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Plus Therapeutics Announces New Employment Inducement Grants
May 17, 2024 17:00 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
May 17, 2024 16:33 ET
|
BriaCell Therapeutics Corp.
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...